1. Home
  2. SCLX vs AERT Comparison

SCLX vs AERT Comparison

Compare SCLX & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • AERT
  • Stock Information
  • Founded
  • SCLX 2011
  • AERT 2012
  • Country
  • SCLX United States
  • AERT Singapore
  • Employees
  • SCLX N/A
  • AERT N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • AERT Professional Services
  • Sector
  • SCLX Health Care
  • AERT Consumer Discretionary
  • Exchange
  • SCLX Nasdaq
  • AERT Nasdaq
  • Market Cap
  • SCLX 33.9M
  • AERT 38.3M
  • IPO Year
  • SCLX N/A
  • AERT N/A
  • Fundamental
  • Price
  • SCLX $5.70
  • AERT $1.11
  • Analyst Decision
  • SCLX Strong Buy
  • AERT
  • Analyst Count
  • SCLX 3
  • AERT 0
  • Target Price
  • SCLX $367.50
  • AERT N/A
  • AVG Volume (30 Days)
  • SCLX 125.0K
  • AERT 291.5K
  • Earning Date
  • SCLX 08-12-2025
  • AERT 08-14-2025
  • Dividend Yield
  • SCLX N/A
  • AERT N/A
  • EPS Growth
  • SCLX N/A
  • AERT N/A
  • EPS
  • SCLX N/A
  • AERT 0.47
  • Revenue
  • SCLX $50,710,000.00
  • AERT $70,851,000.00
  • Revenue This Year
  • SCLX $107.00
  • AERT N/A
  • Revenue Next Year
  • SCLX $82.52
  • AERT N/A
  • P/E Ratio
  • SCLX N/A
  • AERT $2.25
  • Revenue Growth
  • SCLX 7.79
  • AERT 4.38
  • 52 Week Low
  • SCLX $3.60
  • AERT $0.46
  • 52 Week High
  • SCLX $78.05
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 49.86
  • AERT 62.36
  • Support Level
  • SCLX $4.53
  • AERT $1.03
  • Resistance Level
  • SCLX $5.60
  • AERT $1.52
  • Average True Range (ATR)
  • SCLX 0.41
  • AERT 0.20
  • MACD
  • SCLX 0.01
  • AERT 0.02
  • Stochastic Oscillator
  • SCLX 31.96
  • AERT 47.36

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: